NATCO Pharmas Active Pharmaceutical Ingredient (API) facility located in Mekaguda, near Hyderabad, has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration
Zydus Lifesciences Limited has received tentative approval from the U.S. Food and Drug Administration (USFDA) to market Ibrutinib tablets in three strengths — 140 mg, 280 mg, and 420 mg. The approved products are generic versions of Imbruvica®, a widely used cancer medication in the United States.
Diploma in Pharmacy or B-Pharma Degree in Pharmacy or M-Pharma Degree in Pharmacy as approved by any University established by law or any other institution recognized by the State Government in this behalf
Ph.D. in Pharmaceutical Technology, Pharmaceutics, Industrial Pharmacy with M.Pharm, M.S.(Pharm.) in Pharmaceutical Technology (Formulations), Pharmaceutics, Industry Pharmacy. At least one research paper in SCI indexed journal.
A basic degree in Pharmacy. Registration as a Pharmacist under the Pharmacy Act, 1948 as amended from time to time, including any succeeding enactments. First Class Masters Degree in appropriate branch of specialization in Pharmacy